| Product NDC: | 0093-5140 |
| Proprietary Name: | Alendronate Sodium |
| Non Proprietary Name: | Alendronate Sodium |
| Active Ingredient(s): | 5 mg/1 & nbsp; Alendronate Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-5140 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075710 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080206 |
| Package NDC: | 0093-5140-56 |
| Package Description: | 30 TABLET in 1 BOTTLE (0093-5140-56) |
| NDC Code | 0093-5140-56 |
| Proprietary Name | Alendronate Sodium |
| Package Description | 30 TABLET in 1 BOTTLE (0093-5140-56) |
| Product NDC | 0093-5140 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Alendronate Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080206 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | ALENDRONATE SODIUM |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |